Skip to main content

Table 4 Disease-related loci currently mapped to chromosome 22

From: After 'completion': the changing face of human chromosomes 21 and 22

Gene symbol

Total publications

Publications since [1]

OMIM number

Disorder

DGCR

91

18 (20%)

188400

DiGeorge syndrome; velocardiofacial syndrome

DIA1

80

5 (6%)

250800

Methemoglobinemia, type I; methemoglobinemia, type II

CYP2D

75

7 (9%)

124030

Debrisoquine sensitivity; {possible susceptibility to Parkinsonism}

BCR

71

18 (25%)

151410

Chronic myeloid leukemia; acute lymphocytic leukemia

OGS2

60

0 (0%)

145410

Opitz G syndrome, type II

NF2

56

22 (39%)

607379

Neurofibromatosis, type 2; NF2-related somatic meningioma; schwannomatosis

TCN2

53

3 (6%)

275350

Transcobalamin II deficiency

CTLO

51

9 (18%)

218040

Possibly Costello syndrome

ARSA

51

5 (10%)

607574

Metachromatic leukodystrophy

COMT

48

13 (27%)

116790

{Possible susceptibility to schizophrenia}

CECR

48

1 (2%)

115470

Cat eye syndrome

PDGFB

39

2 (5%)

190040

SIS-related meningioma; dermatofibrosarcoma protuberans; giant-cell fibroblastoma

EWSR1

38

1 (3%)

133450

Ewing sarcoma; neuroepithelioma; extraskeletal myxoid chondrosarcoma

CHEK2

24

20 (83%)

604373

Li-Fraumeni syndrome; somatic osteosarcoma; {possible susceptibility to breast cancer}; familial prostate cancer; {possible susceptibility to breast and colorectal cancer}

SOX10

24

10 (42%)

602229

Waardenburg-Shah syndrome; Yemenite deaf-blind hypopigmentation syndrome; neurologic variant Waardenburg-Shah syndrome

NAGA

23

1 (4%)

104170

Schindler disease; Kanzaki disease; mild NAGA deficiency

ACF

21

1 (5%)

125520

Cayler cardiofacial syndrome

MYH9

20

12 (60%)

160775

May-Hegglin anomaly; Fechtner syndrome; Sebastian syndrome; autosomal dominant deafness 17; Epstein syndrome

EP300

16

8 (50%)

602700

Colorectal cancer

TIMP3

16

6 (38%)

188826

Sorsby fundus dystrophy

SMARCB1

16

3 (19%)

601607

Rhabdoid tumors; rhabdoid familial predisposition syndrome

CTHM

16

2 (13%)

217095

? Conotruncal cardiac anomalies

SCZD4

15

2 (13%)

600850

{Possible susceptibility to schizophrenia}

ADSL

15

2 (13%)

608222

Adenylosuccinase deficiency

NEFH

15

0 (0%)

162230

{Possible susceptibility to amyotrophic lateral sclerosis}

SLC5A1

15

0 (0%)

182380

Glucose/galactose malabsorption

CRYBB2

12

2 (17%)

123620

Cataract, cerulean, type 2; cataract, sutural, with punctate and cerulean opacities

GGT1

12

0 (0%)

231950

Glutathioninuria

A4GALT

11

5 (45%)

607922

[Blood group, P system]

HMOX1

11

5 (45%)

141250

Heme oxygenase-1 deficiency

CSF2RB

11

1 (9%)

138981

Pulmonary alveolar proteinosis

ACR

11

0 (0%)

102480

{Possible male infertility due to acrosin deficiency}

MLC1

10

8 (80%)

605908

Megalencephalic leukoencephalopathy with subcortical cysts

SCA10

10

5 (50%)

603516

Spinocerebellar ataxia-10

FBLN1

10

2 (20%)

135820

Synpolydactyly, 3/3'4, associated with metacarpal and metatarsalsynostoses

GP1BB

9

1 (11%)

138720

Bernard-Soulier syndrome, type B; isolated giant platelet disorder

HCF2

9

0 (0%)

142360

Thrombophilia due to heparin cofactor II deficiency

RAC2

8

6 (75%)

602049

Neutrophil immunodeficiency syndrome

PRODH

8

5 (63%)

606810

Hyperprolinemia, type I; {possible susceptibility to schizophrenia}

GGT2

8

0 (0%)

137181

[Familial high serum gamma-glutamyltransferase]

HIRA

8

0 (0%)

600237

{Possible role in CATCH22}

IGLL1

7

1 (14%)

146770

Autosomal agammaglobulinemia recessive

APOL1

6

5 (83%)

603743

{Possible susceptibility to schizophrenia}

XBP1

6

4 (67%)

194355

{Possible susceptibility to schizophrenia}

SCO2

6

4 (67%)

604272

Fatal infantile cardioencephalomyopathy due to cytochrome coxidase deficiency

ECGF1

6

2 (33%)

131222

Myoneurogastrointestinal encephalomyopathy syndrome

PVALB

6

1 (17%)

168890

{Possible role in DiGeorge syndrome}

APOL2

4

4 (100%)

607252

{Possible susceptibility to schizophrenia}

APOL4

4

4 (100%)

607254

{Possible susceptibility to schizophrenia}

MKL1

4

4 (100%)

606078

Acute megakaryoblastic leukemia

LARGE

4

3 (75%)

603590

{Possibly meningioma}

HPS4

4

3 (75%)

606682

Hermansky-Pudlak syndrome

SYN3

4

1 (25%)

602705

{Possible relation to schizophrenia}

KAZA

3

3 (100%)

608207

{Possible susceptibility to Kala-azar}

PSAP2

3

2 (67%)

606230

Chromosome 22q13.3 deletion syndrome

UFD1L

3

1 (33%)

601754

{Possible role in CATCH22}

MN1

3

0 (0%)

156100

Meningioma

ALG12

2

2 (100%)

607144

Congenital disorder of glycosylation, type Ig

FPEVF

2

0 (0%)

604364

Partial epilepsy with variable foci

ARVCF

2

0 (0%)

602269

{Possible role in VCFS}

DFNB40

1

1 (100%)

608264

Autosomal recessive deafness 40

ITS

1

1 (100%)

606960

Insulinoma

  1. The total number of relevant papers and the number of relevant papers since the chromosome 22 publication [1] are listed. As in Table 3, a bold number indicates that there were ten or more post-chromosome locus-related publications; an italic percentage indicates that 25% or more of all locus-related publications appeared after the chromosome sequence was published. Curly brackets indicate examples of mutations that lead to universal susceptibility to a specific infection (diphtheria or polio), to frequent resistance to a specific infection (vivax malaria), protection from nicotine addiction, or other susceptibilities; certain 'nondiseases', mainly genetic variations that lead to apparently abnormal laboratory test values (such as dysalbuminemic euthyroidal hyperthyroxinemia), are included in square brackets. Data were obtained from the NCBI resources OMIM [17] and PubMed [8].